Ikarian Capital »

Relay Therapeutics shares owned by Ikarian Capital

Quarter-by-quarter ownership of Relay Therapeutics (RLAY) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Relay Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Relay Therapeutics held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Relay Therapeutics by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2024-12-31 $2.9M 693k 4.12
2024-09-30 $4.9M 693k 7.08
2021-09-30 $5.0M 160k 31.53

More positions owned by Ikarian Capital

Spdr Ser Tr S&p Biotech Put Option (XBI)
Tyson Foods Cl A Put Option (TSN)
Tarsus Pharmaceuticals (TARS)
Crinetics Pharmaceuticals In (CRNX)
Bridgebio Pharma Call Option (BBIO)
Scholar Rock Hldg Corp Call Option (SRRK)
Amgen Call Option (AMGN)
Insmed Com Par $.01 Call Option (INSM)
Blueprint Medicines (BPMC)
Avidity Biosciences Ord Put Option (RNA)
Sarepta Therapeutics Call Option (SRPT)
Forte Biosciences Com New (FBRX)
Pilgrim's Pride Corporation Put Option (PPC)
Neumora Therapeutics Put Option (NMRA)
Miragen Therapeutics Call Option (VRDN)

View all positions for Ikarian Capital

Top funds holding Relay Therapeutics

Sb Investment Advisers
Vanguard Group
BlackRock
Casdin Capital
Tang Capital Management
Bellevue Group
Norges Bank Investment Management
State Street Corporation
Jpmorgan Chase & Co
Nextech Invest
T. Rowe Price Associates
Geode Capital Management
Dimensional Fund Advisors
Goldman Sachs Group
Eventide Asset Management

View all funds holding Relay Therapeutics